from the same period of last year due to loss on forward contract caused by foreign exchange volatility during the Covid-19 pandemic. 1.2 Cost of goods sold and expenses Consolidated financial statements
. The cost of medical treatments when compared to income from medical treatments decreased 5.06% due to the cost of medical treatments from CMR went down 9.00% and the cost of medical treatments in the
Company’s Board of Directors, disclose the information memorandum of the transaction to the SET, and obtain the approval from the shareholders’ meeting. In the shareholders’ meeting, a resolution shall be
Assets of Wattanapat Hospital Trang Public Company Limited As Wattanapat Hospital Trang Public Company Limited (“the Company”) had approved the resolution of its Board of Director’s Meeting No.4/2019 held
Assets of Wattanapat Hospital Trang Public Company Limited As Wattanapat Hospital Trang Public Company Limited (“the Company”) had approved the resolution of its Board of Director’s Meeting No.4/2019 held
Thailand Enclosure: The Information Memorandum regarding the Disposition of Assets By virtue of the resolution of the Board of Directors’ meeting of Pace Development Corporation Public Company Limited (the
portfolio. Cost of fund for 3Q18 slightly decreased to 2.2% comparing to 2.3% for 3Q17. For the three-month period ended Consolidated Change Sept 30, 2018 Sept 30, 2017 Baht million % Interest expense 1,290
portfolio. Cost of fund for 3Q18 slightly decreased to 2.2% comparing to 2.3% for 3Q17. For the three-month period ended Consolidated Change Sept 30, 2018 Sept 30, 2017 Baht million % Interest expense 1,290
purchase the Company’ s ordinary shares No. 3 ( the “U-W3 Warrants” ) at no cost, totaling Baht 2,172 million; and (b) accepting the assignment of all of UE’s loan owed to BTSG, together with interest
resolution of the increase of registered capital of CCPH, the Company’s subsidiary in which the Company directly holds 100% of the total issued shares, from the current paid-up capital of PHP 212,712,000 or